Raymond James Financial 10-Q 2024-03-31
Filed 2024-05-07. 8 sections, 581K characters. Original on sec.gov · Markdown · JSON
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark one)
| ☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF | ||||
| THE SECURITIES EXCHANGE ACT OF 1934 | |||||
| For the quarterly period ended March 31, 2024 |
or
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF | ||||
| THE SECURITIES EXCHANGE ACT OF 1934 |
| For the transition period from | to |
Commission File Number: 1-9109
RAYMOND JAMES FINANCIAL, INC.
(Exact name of registrant as specified in its charter)
| Florida | 59-1517485 | |||||||
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
880 Carillon Parkway, St. Petersburg, Florida 33716
(Address of principal executive offices) (Zip Code)
(727) 567-1000
(Registrant’s telephone number, including area code)
None
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Exchange Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common Stock, $.01 par value | RJF | New York Stock Exchange | ||||||
| Depositary Shares, Each Representing a 1/40th Interest in a Share of 6.375% Fixed-to-Floating Rate Series B Non-Cumulative Perpetual Preferred Stock | RJF PrB | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes x No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | x | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
| Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ☐ No ☒
Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date.
207,276,768 shares of common stock as of May 3, 2024
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES
| INDEX | |||||||||||
| PAGE | |||||||||||
| PART I | FINANCIAL INFORMATION | ||||||||||
| Item 1. | Financial Statements (Unaudited) | 3 | |||||||||
| Condensed Consolidated Statements of Financial Condition (Unaudited) | 3 | ||||||||||
| Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) | 4 | ||||||||||
| Condensed Consolidated Statements of Changes in Shareholders’ Equity (Unaudited) | 5 | ||||||||||
| Condensed Consolidated Statements of Cash Flows (Unaudited) | 6 | ||||||||||
| Notes to Condensed Consolidated Financial Statements (Unaudited) | |||||||||||
| Note 1 - Organization and basis of presentation | 8 | ||||||||||
| Note 2 - Update of significant accounting policies | 9 | ||||||||||
| Note 3 - Fair value | 10 | ||||||||||
| Note 4 - Available-for-sale securities | 16 | ||||||||||
| Note 5 - Derivative assets and derivative liabilities | 19 | ||||||||||
| Note 6 - Collateralized agreements and financings | 21 | ||||||||||
| Note 7 - Bank loans, net | 23 | ||||||||||
| Note 8 - Loans to financial advisors, net | 30 | ||||||||||
| Note 9 - Variable interest entities | 30 | ||||||||||
| Note 10 - Goodwill and identifiable intangible assets, net | 31 | ||||||||||
| Note 11 - Other assets | 32 | ||||||||||
| Note 12 - Leases | 32 | ||||||||||
| Note 13 - Bank deposits | 33 | ||||||||||
| Note 14 - Other borrowings | 34 | ||||||||||
| Note 15 - Income taxes | 35 | ||||||||||
| Note 16 - Commitments, contingencies and guarantees | 35 | ||||||||||
| Note 17 - Shareholders’ equity | 38 | ||||||||||
| Note 18 - Revenues | 41 | ||||||||||
| Note 19 - Interest income and interest expense | 45 | ||||||||||
| Note 20 - Share-based compensation | 45 | ||||||||||
| Note 21 - Regulatory capital requirements | 46 | ||||||||||
| Note 22 - Earnings per share | 48 | ||||||||||
| Note 23 - Segment information | 49 | ||||||||||
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 51 | |||||||||
| Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 92 | |||||||||
| Item 4. | Controls and Procedures | 92 | |||||||||
| PART II | OTHER INFORMATION | ||||||||||
| Item 1. | Legal Proceedings | 93 | |||||||||
| Item 1A. | Risk Factors | 93 | |||||||||
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 93 | |||||||||
| Item 3. | Defaults Upon Senior Securities | 93 | |||||||||
| Item 4. | Mine Safety Disclosures | 93 | |||||||||
| Item 5. | Other Information | 94 | |||||||||
| Item 6. | Exhibits | 94 | |||||||||
| Signatures | 95 |
PART I. FINANCIAL INFORMATION
Item 1. FINANCIAL STATEMENTS
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
(Unaudited)
| $ in millions, except per share amounts | March 31, 2024 | September 30, 2023 | ||||||||||||
| Assets: | ||||||||||||||
| Cash and cash equivalents | $ | 10,001 | $ | 9,313 | ||||||||||
| Assets segregated for regulatory purposes and restricted cash | 3,705 | 3,235 | ||||||||||||
| Collateralized agreements | 727 | 418 | ||||||||||||
| Financial instruments, at fair value: | ||||||||||||||
| Trading assets ($1,257 and $1,062 pledged as collateral) | 1,434 | 1,187 | ||||||||||||
| Available-for-sale securities ($20 and $22 pledged as collateral) | 9,031 | 9,181 | ||||||||||||
| Derivative assets | 206 | 265 | ||||||||||||
| Other investments ($6 and $7 pledged as collateral) | 306 | 306 | ||||||||||||
| Brokerage client receivables, net | 2,782 | 2,525 | ||||||||||||
| Other receivables, net | 1,999 | 1,608 | ||||||||||||
| Bank loans, net | 44,099 | 43,775 | ||||||||||||
| Loans to financial advisors, net | 1,190 | 1,136 | ||||||||||||
| Deferred income taxes, net | 656 | 711 | ||||||||||||
| Goodwill and identifiable intangible assets, net | 1,894 | 1,907 | ||||||||||||
| Other assets | 3,202 | 2,793 | ||||||||||||
| Total assets | $ | 81,232 | $ | 78,360 | ||||||||||
| Liabilities and shareholders’ equity: | ||||||||||||||
| Bank deposits | $ | 54,843 | $ | 54,199 | ||||||||||
| Collateralized financings | 955 | 337 | ||||||||||||
| Financial instrument liabilities, at fair value: | ||||||||||||||
| Trading liabilities | 904 | 716 | ||||||||||||
| Derivative liabilities | 365 | 490 | ||||||||||||
| Brokerage client payables | 6,038 | 5,447 | ||||||||||||
| Accrued compensation, commissions and benefits | 1,757 | 1,914 | ||||||||||||
| Other payables | 2,053 | 1,931 | ||||||||||||
| Other borrowings | 1,299 | 1,100 | ||||||||||||
| Senior notes payable | 2,039 | 2,039 | ||||||||||||
| Total liabilities | 70,253 | 68,173 | ||||||||||||
| Commitments and contingencies (see Note 16) | ||||||||||||||
| Shareholders’ equity | ||||||||||||||
| Preferred stock | 79 | 79 | ||||||||||||
| Common stock; $.01 par value; 650,000,000 shares authorized; 249,799,231 shares issued and 207,318,494 shares outstanding as of March 31, 2024; 248,728,805 shares issued and 208,769,095 shares outstanding as of September 30, 2023 | 2 | 2 | ||||||||||||
| Additional paid-in capital | 3,186 | 3,143 | ||||||||||||
| Retained earnings | 10,988 | 10,213 | ||||||||||||
| Treasury stock, at cost; 42,480,737 and 39,959,710 common shares as of March 31, 2024 and September 30, 2023, respectively | (2,547) | (2,252) | ||||||||||||
| Accumulated other comprehensive loss | (724) | (971) | ||||||||||||
| Total equity attributable to Raymond James Financial, Inc. | 10,984 | 10,214 | ||||||||||||
| Noncontrolling interests | (5) | (27) | ||||||||||||
| Total shareholders’ equity | 10,979 | 10,187 | ||||||||||||
| Total liabilities and shareholders’ equity | $ | 81,232 | $ | 78,360 |
See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited).
RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(Unaudited)
| Three months ended March 31, | Six months ended March 31, | |||||||||||||||||||||||||
| in millions, except per share amounts | 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||
| Revenues: | ||||||||||||||||||||||||||
| Asset management and related administrative fees | $ | 1,516 | $ | 1,302 | $ | 2,923 | $ | 2,544 | ||||||||||||||||||
| Brokerage revenues: | ||||||||||||||||||||||||||
| Securities commissions | 414 | 369 | 797 | 721 | ||||||||||||||||||||||
| Principal transactions | 114 | 127 | 253 | 259 | ||||||||||||||||||||||
| Total brokerage revenues | 528 | 496 | 1,050 | 980 | ||||||||||||||||||||||
| Account and service fees | 335 | 258 | 654 | 547 | ||||||||||||||||||||||
| Investment banking | 179 | 154 | 360 | 295 | ||||||||||||||||||||||
| Interest income | 1,049 | 915 | 2,102 | 1,742 | ||||||||||||||||||||||
| Other | 31 | 32 | 69 | 76 | ||||||||||||||||||||||
| Total revenues | 3,638 | 3,157 | 7,158 | 6,184 | ||||||||||||||||||||||
| Interest expense | (520) | (284) | (1,027) | (525) | ||||||||||||||||||||||
| Net revenues | 3,118 | 2,873 | 6,131 | 5,659 | ||||||||||||||||||||||
| Non-interest expenses: | ||||||||||||||||||||||||||
| Compensation, commissions and benefits | 2,043 | 1,820 | 3,964 | 3,556 | ||||||||||||||||||||||
| Non-compensation expenses: | ||||||||||||||||||||||||||
| Communications and information processing | 165 | 153 | 315 | 292 | ||||||||||||||||||||||
| Occupancy and equipment | 73 | 68 | 145 | 134 | ||||||||||||||||||||||
| Business development | 60 | 54 | 121 | 110 | ||||||||||||||||||||||
| Investment sub-advisory fees | 44 | 36 | 84 | 70 | ||||||||||||||||||||||
| Professional fees | 33 | 38 | 65 | 70 | ||||||||||||||||||||||
| Bank loan provision for credit losses | 21 | 28 | 33 | 42 | ||||||||||||||||||||||
Showing the first 8K of 302K characters. Open the full section
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
| INDEX | |||||
| PAGE | |||||
| Factors affecting “forward-looking statements” | 52 | ||||
| Introduction | 52 | ||||
| Executive overview | 52 | ||||
| Reconciliation of non-GAAP financial measures to GAAP financial measures | 55 | ||||
| Net interest analysis | 58 | ||||
| Results of operations | |||||
| Private Client Group | 63 | ||||
| Capital Markets | 67 | ||||
| Asset Management | 68 | ||||
| Bank | 71 | ||||
| Other | 72 | ||||
| Statement of financial condition analysis | 73 | ||||
| Liquidity and capital resources | 74 | ||||
| Regulatory | 80 | ||||
| Critical accounting estimates | 81 | ||||
| Accounting standards update | 82 | ||||
| Risk management | 82 |
| RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES Management’s Discussion and Analysis | Index |
FACTORS AFFECTING “FORWARD-LOOKING STATEMENTS”
Certain statements made in this Quarterly Report on Form 10-Q may constitute “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning future strategic objectives, business prospects, anticipated savings, financial results (including expenses, earnings, liquidity, cash flow and capital expenditures), industry or market conditions (including changes in interest rates and inflation), demand for and pricing of our products (including cash sweep and deposit offerings), acquisitions, anticipated results of litigation, regulatory developments, and general economic conditions. In addition, words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “projects,” and future or conditional verbs such as “will,” “may,” “could,” “should,” and “would,” as well as any other statement that necessarily depends on future events, are intended to identify forward-looking statements. Forward-looking statements are not guarantees, and they involve risks, uncertainties and assumptions. Although we make such statements based on assumptions that we believe to be reasonable, there can be no assurance that actual results will not differ materially from those expressed in the forward-looking statements. We caution investors not to rely unduly on any forward-looking statements and urge you to carefully consider the risks described in our filings with the Securities and Exchange Commission (the “SEC”) from time to time, including our most recent Annual Report on Form 10-K, and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, which are available at www.raymondjames.com and the SEC’s website at www.sec.gov. We expressly disclaim any obligation to update any forward-looking statement in the event it later turns out to be inaccurate, whether as a result of new information, future events, or otherwise.
INTRODUCTION
The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to help the reader understand the results of our operations and financial condition. This MD&A is provided as a supplement to, and should be read in conjunction with, our condensed consolidated financial statements and accompanying notes to condensed consolidated financial statements. Where “NM” is used in various percentage change computations, the computed percentage change has been determined to be not meaningful.
We operate as a financial holding company and bank holding company. Results in the businesses in which we operate are highly correlated to general economic conditions and, more specifically, to the direction of the U.S. equity and fixed income markets, changes in interest rates, market volatility, corporate and mortgage lending markets and commercial and residential credit trends. Overall market conditions, economic, political and regulatory trends, and industry competition are among the factors which could affect us and which are unpredictable and beyond our control. These factors affect the financial decisions made by market participants, including investors, borrowers, and competitors, impacting their level of participation in the financial markets. These factors also impact the level of investment banking activity and asset valuations, which ultimately affect our business results.
EXECUTIVE OVERVIEW
Quarter ended March 31, 2024 compared with the quarter ended March 31, 2023
For our fiscal second quarter of 2024, we generated net revenues of $3.12 billion and pre-tax income of $609 million, each 9% higher than the prior-year quarter. Our net income available to common shareholders of $474 million increased 12%, and our earnings per diluted share were $2.22, reflecting an increase of 15%. Our annualized return on common equity (“ROCE”) for the quarter was 17.5%, compared with 17.3% for the prior-year quarter, and our annualized return on tangible common equity (“ROTCE”) was 21.0%(1), compared with 21.3%(1) for the prior-year quarter. Excluding the impact of $26 million of expenses related to acquisitions completed in prior years, such as compensation related to retention awards and amortization of identifiable intangible assets, our adjusted net income available to common shareholders was $494 million(1) for the three months ended March 31, 2024, an increase of 11% compared with adjusted net income available to common shareholders for the prior-year quarter. Our adjusted earnings per diluted share were $2.31(1), an increase of 14% compared with the prior-year quarter. Adjusted annualized ROCE for the quarter was 18.3%(1) and adjusted annualized ROTCE was 21.8%(1) compared with adjusted annualized ROCE of 18.2%(1) and adjusted annualized ROTCE of 22.3%(1) for the prior-year quarter.
(1)ROTCE, adjusted net income available to common shareholders, adjusted earnings per diluted share, adjusted annualized ROCE, and adjusted annualized ROTCE are non-GAAP financial measures. Please see the “Reconciliation of non-GAAP financial measures to GAAP financial measures” in this MD&A for a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures, and for other important disclosures.
| RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES Management’s Discussion and Analysis | Index |
The increase in net revenues compared with the prior-year quarter was primarily due to higher asset management and related administrative fees, largely the result of higher PCG client assets in fee-based accounts at the beginning of the current quarter compared with the prior-year quarter. Brokerage revenues also increased compared with the prior-year quarter largely due to an increase in client activity in the PCG segment, partially offset by lower fixed income brokerage revenues due to lower market volatility compared with the prior-year quarter. Investment banking revenues increased compared with the prior-year quar
Showing the first 8K of 258K characters. Open the full section
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See “Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations - Risk management” of this Form 10-Q for our quantitative and qualitative disclosures about market risk.
Item 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Disclosure controls are procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, such as this report, are recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls are also designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute, assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Securities Exchange Act of 1934 Rule 13a-15(b) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective.
Changes in Internal Control over Financial Reporting
There were no changes during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
| RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES Management’s Discussion and Analysis | Index |
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
None.
Item 1A. RISK FACTORS
Not applicable.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
We did not have any sales of unregistered securities for the six months ended March 31, 2024.
We purchase our own stock from time to time in conjunction with a number of activities, each of which is described in the following paragraphs. The following table presents information on our purchases of our own stock, on a monthly basis, for the six months ended March 31, 2024.
| Total number of shares purchased | Average price per share | Number of shares purchased as part of publicly announced plans or programs | Approximate dollar value (in millions) at each month-end of securities that may yet be purchased under the plans or programs | ||||||||||||||||||||
| October 1, 2023 – October 31, 2023 | 2,602 | $ | 100.13 | — | $750 | ||||||||||||||||||
| November 1, 2023 – November 30, 2023 | 516,466 | $ | 99.63 | 439,678 | $1,500 | ||||||||||||||||||
| December 1, 2023 – December 31, 2023 | 970,735 | $ | 110.03 | 968,566 | $1,393 | ||||||||||||||||||
| First quarter | 1,489,803 | $ | 106.40 | 1,408,244 | |||||||||||||||||||
| January 1, 2024 – January 31, 2024 | 31,211 | $ | 110.95 | — | $1,393 | ||||||||||||||||||
| February 1, 2024 – February 29, 2024 | 344,673 | $ | 118.60 | 336,110 | $1,354 | ||||||||||||||||||
| March 1, 2024 – March 31, 2024 | 1,361,324 | $ | 122.78 | 1,358,927 | $1,187 | ||||||||||||||||||
| Second quarter | 1,737,208 | $ | 121.74 | 1,695,037 | |||||||||||||||||||
| Fiscal year-to-date total | 3,227,011 | $ | 114.66 | 3,103,281 |
In November 2023, the Board of Directors authorized repurchase of our common stock in an aggregate amount of up to $1.5 billion, which replaced the previous authorization.
In the preceding table, the total number of shares purchased includes shares purchased pursuant to the Restricted Stock Trust Fund, which was established to acquire our common stock in the open market and used to settle RSUs granted as a retention vehicle for certain employees of our wholly-owned Canadian subsidiaries. For more information on this trust fund, see Note 2 of the Notes to Consolidated Financial Statements of our 2023 Form 10-K and Note 9 of the Notes to Condensed Consolidated Financial Statements of this Form 10-Q. These activities do not utilize the repurchase authorization presented in the preceding table.
The total number of shares purchased also includes shares repurchased as a result of employees surrendering shares as payment for option exercises or withholding taxes. These activities do not utilize the repurchase authorization presented in the preceding table.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
| RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES Management’s Discussion and Analysis | Index |
Item 5. OTHER INFORMATION
None of our directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the three months ended March 31, 2024.
Item 6. EXHIBITS
| RAYMOND JAMES FINANCIAL, INC. AND SUBSIDIARIES Management’s Discussion and Analysis | Index |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| RAYMOND JAMES FINANCIAL, INC. | |||||||||||
| (Registrant) | |||||||||||
| Date: | May 7, 2024 | /s/ Paul C. Reilly | |||||||||
| Paul C. Reilly | |||||||||||
| Chair and Chief Executive Officer | |||||||||||
| Date: | May 7, 2024 | /s/ Paul M. Shoukry | |||||||||
| Paul M. Shoukry | |||||||||||
| President and Chief Financial Officer |